Cleveland Clinic-Led Trial Finds That Cerebral Embolic Protection Device Reduced Risk of Disabling Stroke Following TAVR Procedure
September 19, 2022
September 19, 2022
CLEVELAND, Ohio, Sept. 19 (TNSjou) -- The Cleveland Clinic issued the following news release on Sept. 17, 2022:
Findings from a Cleveland Clinic-led trial show that a Cerebral Embolic Protection (CEP) device reduced the risk of disabling strokes by capturing and removing tiny pieces of calcium and other fragments resulting from transcatheter aortic valve replacement (TAVR) before they can reach the brain.
Findings from the "Cerebral Embolic Protection During Transc . . .
Findings from a Cleveland Clinic-led trial show that a Cerebral Embolic Protection (CEP) device reduced the risk of disabling strokes by capturing and removing tiny pieces of calcium and other fragments resulting from transcatheter aortic valve replacement (TAVR) before they can reach the brain.
Findings from the "Cerebral Embolic Protection During Transc . . .